![]() |
RELATED RESOURCES |
SEC Filings:TENXTENAX THERAPEUTICS INC0.302001
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2022 | Form SC 13G | Beneficial Ownership Statement | 06/21/2022 | N/A |
Form SC 13D/A | Acquistion of beneficial ownership | 06/17/2022 | N/A | |
Form 8-K* | Current Report* | 06/16/2022 | 06/10/2022 | |
Form 4 | Insider Transaction | 06/10/2022 | 06/09/2022 | |
Form 4 | Insider Transaction | 06/10/2022 | 06/09/2022 | |
Form 4 | Insider Transaction | 06/10/2022 | 06/09/2022 | |
Form 4 | Insider Transaction | 06/10/2022 | 06/09/2022 | |
Form 4 | Insider Transaction | 06/10/2022 | 06/09/2022 | |
Form 4 | Insider Transaction | 06/10/2022 | 06/09/2022 | |
Form 4 | Insider Transaction | 06/10/2022 | 06/09/2022 | |
Form 8-K* | Current Report* | 06/10/2022 | 06/09/2022 | |
Form 424B3 | Prospectus | 06/03/2022 | N/A | |
Form EFFECT | Notice of Effectiveness | 06/03/2022 | N/A | |
Form D | Notice of Exempt Offering of Securities | 06/01/2022 | N/A | |
Form S-3 | Registration statement | 05/25/2022 | N/A |